Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found. The research, which will be presented to delegates at the ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] Technology appraisal guidance 12 February 2025 Abaloparatide for treating ...

We use tools such as Google Analytics, Hotjar, Google Optimize and Loop11 to help us anonymously measure how you use our websites. This allows us to make improvements based on our users' needs.

We have also today published a new discussion aid to support shared decision making about HRT, focusing on the key risks and benefits to consider. The guideline clarifies that whilst HRT has some ...

The London School of Economics and Political Science (LSE) have joined forces with NICE to offer a unique solution - the Executive MSc in Healthcare Decision-Making.

There is a simple discount patient access scheme for avapritinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non‑NHS organisations can contact ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

Suggested remit: To appraise the clinical and cost effectiveness of inhaled treprostinil within its marketing authorisation for treating pulmonary hypertension caused by interstitial lung disease.

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee C. Committee members are asked to declare any interests in the technology being ...

Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their cholesterol during 2023/24, the largest number on record and almost 900,000 more ...